Genpact (G) Financials

$49.68 +0.11 (+0.22%)

As of 03:01 PM Eastern

Annual Income Statements for Genpact

This table shows Genpact's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	240	270	263	564	305	308	369	353	631	514
Consolidated Net Income / (Loss)	240	268	261	563	305	308	369	353	631	514
Net Income / (Loss) Continuing Operations	240	268	261	281	305	308	369	353	631	514
Total Pre-Tax Income	302	330	321	362	399	400	483	465	602	677
Total Operating Income	334	341	331	348	429	439	509	502	631	702
Total Gross Profit	967	1,016	1,055	1,079	1,226	1,291	1,432	1,536	1,571	1,690
Total Revenue	2,461	2,571	2,737	3,001	3,521	3,709	4,022	4,371	4,477	4,767
Operating Revenue	2,461	2,571	2,737	3,001	3,521	3,709	4,022	4,371	4,477	4,767
Total Cost of Revenue	1,494	1,554	1,681	1,922	2,295	2,418	2,590	2,835	2,906	3,077
Operating Cost of Revenue	1,494	1,554	1,681	1,922	2,295	2,418	2,590	2,835	2,906	3,077
Total Operating Expenses	633	675	724	731	796	853	923	1,034	940	988
Selling, General & Admin Expense	608	653	689	694	795	790	866	938	913	967
Amortization Expense	29	27	36	39	33	43	58	43	31	26
Other Operating Expenses / (Income)	-3.32	-4.94	-1.66	-1.85	-31	19	-1.20	53	-4.72	-5.62
Total Other Income / (Expense), net	-32	-12	-11	14	-30	-38	-26	-37	-29	-25
Interest & Investment Income	-42	-24	-36	-37	-43	-49	-51	-52	-48	-47
Other Income / (Expense), net	9.63	12	26	51	14	11	26	15	19	22
Income Tax Expense	62	62	60	81	95	92	114	112	-29	163
Basic Earnings per Share	$1.11	$1.30	$1.36	$1.48	$1.60	$1.62	$1.97	$1.92	$3.46	$2.88
Weighted Average Basic Shares Outstanding	216.61M	206.86M	193.86M	190.67M	190.07M	190.40M	187.80M	184.18M	182.35M	178.39M
Diluted Earnings per Share	$1.09	$1.28	$1.34	$1.45	$1.56	$1.57	$1.91	$1.88	$3.41	$2.85
Weighted Average Diluted Shares Outstanding	219.15M	210.13M	197.05M	193.98M	195.16M	195.78M	192.96M	188.09M	185.14M	180.44M
Weighted Average Basic & Diluted Shares Outstanding	216.10M	207.40M	193.50M	190.60M	190.40M	188.14M	185.17M	183.98M	180.73M	175.67M
Cash Dividends to Common per Share	-	$0.00	$0.24	$0.30	$0.34	$0.39	$0.11	$0.13	$0.55	$0.61

This table shows Genpact's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	96	90	106	116	118	291	117	122	133	142
Consolidated Net Income / (Loss)	96	90	106	116	118	291	117	122	133	142
Net Income / (Loss) Continuing Operations	96	90	106	116	118	291	117	122	133	142
Total Pre-Tax Income	121	123	138	150	155	158	156	162	175	183
Total Operating Income	131	128	145	157	166	163	160	170	182	190
Total Gross Profit	394	385	370	390	403	408	396	416	431	446
Total Revenue	1,111	1,103	1,089	1,106	1,136	1,146	1,131	1,176	1,211	1,249
Operating Revenue	1,111	1,103	1,089	1,106	1,136	1,146	1,131	1,176	1,211	1,249
Total Cost of Revenue	717	717	719	715	733	739	735	760	780	803
Operating Cost of Revenue	717	717	719	715	733	739	735	760	780	803
Total Operating Expenses	263	257	225	233	237	245	236	246	250	256
Selling, General & Admin Expense	231	237	216	229	230	237	235	240	243	249
Amortization Expense	11	9.86	8.26	8.26	7.50	7.45	6.93	6.56	6.50	6.50
Other Operating Expenses / (Income)	21	11	0.39	-4.96	-0.09	-0.05	-5.47	-0.07	-0.02	-0.06
Total Other Income / (Expense), net	-9.77	-4.63	-6.64	-6.95	-11	-4.26	-3.62	-7.83	-6.16	-7.63
Interest & Investment Income	-13	-16	-9.63	-12	-13	-13	-10	-14	-12	-11
Other Income / (Expense), net	3.63	11	2.99	5.19	2.47	8.66	6.62	5.70	6.22	3.42
Income Tax Expense	25	33	32	34	37	-133	39	40	43	41
Basic Earnings per Share	$0.52	$0.49	$0.58	$0.63	$0.65	$1.60	$0.65	$0.68	$0.75	$0.80
Weighted Average Basic Shares Outstanding	183.31M	184.18M	183.80M	183.23M	181.40M	182.35M	180.42M	179.65M	177.60M	178.39M
Diluted Earnings per Share	$0.51	$0.48	$0.57	$0.63	$0.64	$1.57	$0.64	$0.67	$0.74	$0.80
Weighted Average Diluted Shares Outstanding	187.40M	188.09M	187.59M	185.83M	183.80M	185.14M	181.94M	180.91M	179.71M	180.44M
Weighted Average Basic & Diluted Shares Outstanding	183.26M	183.98M	184.15M	181.32M	181.41M	180.73M	179.98M	178.18M	176.36M	175.67M

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	8.08	-13	44	-72	110	226	239	-164	-71	85
Net Cash From Operating Activities	327	346	359	340	428	584	694	444	491	615
Net Cash From Continuing Operating Activities	327	346	359	341	428	584	694	444	491	615
Net Income / (Loss) Continuing Operations	240	268	261	283	305	308	369	353	631	514
Consolidated Net Income / (Loss)	240	268	261	281	305	308	369	353	631	514
Depreciation Expense	54	55	59	65	96	116	109	87	73	70
Amortization Expense	42	29	38	43	34	46	61	45	33	29
Non-Cash Adjustments To Reconcile Net Income	37	-15	9.64	-17	-14	20	160	138	55	-6.86
Changes in Operating Assets and Liabilities, net	-46	10	-8.20	-33	6.25	94	-5.54	-180	-301	9.94
Net Cash From Investing Activities	-100	-126	-362	-276	-357	-266	-123	-37	-79	-106
Net Cash From Continuing Investing Activities	-100	-126	-362	-276	-357	-266	-123	-37	-79	-106
Purchase of Property, Plant & Equipment	-62	-82	-57	-85	-75	-70	-53	-51	-55	-83
Acquisitions	-40	-62	-306	-187	-34	-197	-76	-3.81	-4.04	-2.47
Purchase of Investments	-	-	-	-	-	-	-	0.00	0.00	-23
Sale of Property, Plant & Equipment	1.49	0.55	1.74	0.67	1.75	0.61	6.38	0.06	0.03	2.64
Divestitures	-	17	-	0.00	-250	0.00	0.14	18	-20	0.00
Net Cash From Financing Activities	-219	-233	47	-135	40	-92	-333	-571	-483	-425
Net Cash From Continuing Financing Activities	-219	-233	47	-135	40	-92	-333	-571	-483	-425
Repayment of Debt	-2,258	-103	-328	-295	-661	-475	-301	-746	-321	-509
Repurchase of Common Equity	-227	-345	-220	-154	-30	-137	-298	-214	-225	-253
Payment of Dividends	-	-	-47	-57	-65	-74	-80	-92	-100	-108
Issuance of Debt	2,252	200	645	379	800	610	350	500	148	450
Issuance of Common Equity	16	18	16	14	20	25	35	28	39	17
Other Financing Activities, net	-0.86	-2.25	-19	-22	-24	-41	-38	-47	-24	-22
Cash Interest Paid	21	20	28	41	45	49	46	51	48	69
Cash Income Taxes Paid	72	47	66	81	104	194	32	146	157	114

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	104	130	-109	-57	67	28	-98	440	98	-355
Net Cash From Operating Activities	226	230	-34	171	162	192	-26	209	228	203
Net Cash From Continuing Operating Activities	226	230	-34	171	162	192	-26	209	228	203
Net Income / (Loss) Continuing Operations	96	90	106	116	118	291	117	122	133	142
Consolidated Net Income / (Loss)	96	90	106	116	118	291	117	122	133	142
Depreciation Expense	20	19	19	18	18	18	17	17	17	18
Amortization Expense	11	10	8.74	8.75	7.99	7.95	7.42	7.11	7.21	7.16
Non-Cash Adjustments To Reconcile Net Income	18	95	9.87	-24	-23	92	-8.95	19	36	-53
Changes in Operating Assets and Liabilities, net	81	16	-178	52	42	-218	-158	44	35	89
Net Cash From Investing Activities	-8.23	0.66	-34	-12	-14	-19	-25	-20	-20	-41
Net Cash From Continuing Investing Activities	-8.23	0.66	-34	-12	-14	-19	-25	-20	-20	-41
Purchase of Property, Plant & Equipment	-8.37	-15	-13	-11	-13	-18	-24	-19	-20	-20
Acquisitions	0.13	-1.81	-21	-0.88	-0.86	19	-0.67	-0.59	-0.53	-0.68
Sale of Property, Plant & Equipment	0.02	0.00	0.01	0.01	0.00	0.00	0.00	0.12	0.01	2.51
Net Cash From Financing Activities	-114	-100	-41	-216	-81	-145	-48	251	-110	-517
Net Cash From Continuing Financing Activities	-114	-100	-41	-216	-81	-145	-48	251	-110	-517
Repayment of Debt	-63	-310	-56	-160	-57	-48	-27	-62	-10	-410
Payment of Dividends	-23	-23	-25	-25	-25	-25	-27	-27	-27	-27
Issuance of Common Equity	4.60	15	16	16	2.71	4.85	6.80	2.92	2.45	5.05
Other Financing Activities, net	-2.86	-	-21	-0.15	-1.37	-1.84	-21	-0.32	-0.17	-0.97
Cash Interest Paid	7.26	21	6.11	16	9.00	16	11	19	8.56	30
Cash Income Taxes Paid	36	32	23	44	57	33	20	26	32	36

This table presents Genpact's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,793	2,886	3,450	3,529	4,454	4,874	4,975	4,589	4,806	4,987
Total Current Assets	1,195	1,227	1,434	1,355	1,552	1,749	1,922	1,779	1,892	2,080
Cash & Equivalents	451	423	504	368	467	680	899	647	584	648
Short-Term Investments	-	-	-	-	-	-	-	-	0.00	23
Accounts Receivable	590	615	693	774	914	881	888	995	1,116	1,199
Prepaid Expenses	154	189	236	212	170	187	134	138	192	210
Plant, Property, & Equipment, net	175	193	207	213	254	231	215	181	190	208
Total Noncurrent Assets	1,423	1,466	1,809	1,962	2,648	2,894	2,839	2,629	2,724	2,699
Goodwill	1,038	1,069	1,337	1,394	1,574	1,696	1,731	1,684	1,684	1,670
Intangible Assets	99	79	132	177	231	237	170	90	53	27
Noncurrent Deferred & Refundable Income Taxes	99	70	77	75	90	107	106	135	299	269
Other Noncurrent Operating Assets	180	242	262	315	753	854	832	719	689	733
Total Liabilities & Shareholders' Equity	2,793	2,886	3,450	3,529	4,454	4,874	4,975	4,589	4,806	4,987
Total Liabilities	1,489	1,595	2,021	2,125	2,765	3,039	3,078	2,763	2,557	2,598
Total Current Liabilities	594	731	839	976	910	1,203	1,309	1,103	1,318	964
Short-Term Debt	61	199	209	328	104	284	383	177	442	26
Accounts Payable	10	9.77	15	43	22	14	25	36	28	36
Current Deferred & Payable Income Tax Liabilities	24	24	30	34	43	42	47	45	38	35
Other Current Liabilities	500	498	584	571	742	863	853	845	809	866
Total Noncurrent Liabilities	895	863	1,182	1,149	1,855	1,837	1,769	1,659	1,239	1,634
Long-Term Debt	737	698	1,007	976	1,340	1,307	1,272	1,249	825	1,195
Noncurrent Deferred & Payable Income Tax Liabilities	2.09	2.42	6.75	8.08	3.99	1.52	3.94	4.18	12	16
Other Noncurrent Operating Liabilities	155	163	169	165	511	528	493	406	403	423
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,304	1,287	1,424	1,404	1,689	1,834	1,897	1,826	2,248	2,390
Total Preferred & Common Equity	1,304	1,287	1,424	1,404	1,689	1,834	1,897	1,826	2,248	2,390
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,304	1,287	1,424	1,404	1,689	1,834	1,897	1,826	2,248	2,390
Common Stock	1,344	1,386	1,423	1,473	1,572	1,638	1,719	1,779	1,886	1,947
Retained Earnings	412	358	356	438	649	742	732	780	1,085	1,237
Accumulated Other Comprehensive Income / (Loss)	-451	-458	-355	-507	-532	-545	-554	-733	-723	-794

This table presents Genpact's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	4,537	4,506	4,482	4,599	4,741	5,178	5,326
Total Current Assets	1,758	1,734	1,748	1,870	1,830	2,266	2,401
Cash & Equivalents	519	552	491	541	478	914	1,023
Accounts Receivable	994	1,005	1,008	1,054	1,147	1,160	1,214
Prepaid Expenses	230	176	249	274	205	192	164
Plant, Property, & Equipment, net	180	179	180	180	194	200	208
Total Noncurrent Assets	2,598	2,593	2,554	2,550	2,716	2,713	2,717
Goodwill	1,681	1,687	1,685	1,678	1,680	1,678	1,683
Intangible Assets	101	80	71	62	46	40	33
Noncurrent Deferred & Refundable Income Taxes	112	131	131	138	282	277	289
Other Noncurrent Operating Assets	704	695	667	672	708	718	712
Total Liabilities & Shareholders' Equity	4,537	4,506	4,482	4,599	4,741	5,178	5,326
Total Liabilities	2,805	2,581	2,549	2,589	2,442	2,841	2,931
Total Current Liabilities	1,633	945	931	979	1,185	1,198	1,295
Short-Term Debt	735	206	129	81	476	426	426
Accounts Payable	28	23	42	27	28	28	19
Current Deferred & Payable Income Tax Liabilities	107	64	94	131	39	44	53
Other Current Liabilities	754	652	667	740	642	700	797
Total Noncurrent Liabilities	1,172	1,636	1,618	1,610	1,257	1,643	1,636
Long-Term Debt	747	1,243	1,237	1,230	818	1,208	1,201
Noncurrent Deferred & Payable Income Tax Liabilities	3.63	4.49	3.79	3.82	12	10	12
Other Noncurrent Operating Liabilities	421	389	378	376	427	425	423
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,732	1,925	1,933	2,009	2,298	2,338	2,395
Total Preferred & Common Equity	1,732	1,925	1,933	2,009	2,298	2,338	2,395
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,732	1,925	1,933	2,009	2,298	2,338	2,395
Common Stock	1,742	1,797	1,833	1,858	1,881	1,902	1,924
Retained Earnings	745	831	801	894	1,145	1,176	1,207
Accumulated Other Comprehensive Income / (Loss)	-755	-702	-701	-742	-727	-740	-736

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.97%	4.46%	6.46%	9.64%	17.32%	5.36%	8.43%	8.68%	2.42%	6.48%
EBITDA Growth	20.06%	-0.77%	3.86%	11.72%	13.13%	6.65%	15.25%	-7.87%	16.45%	8.81%
EBIT Growth	21.16%	2.82%	0.94%	11.85%	10.96%	1.48%	18.94%	-3.20%	25.65%	11.36%
NOPAT Growth	17.32%	4.27%	-2.67%	0.35%	21.17%	3.04%	15.26%	-2.00%	73.36%	-19.42%
Net Income Growth	24.79%	11.56%	-2.51%	115.95%	-45.87%	1.11%	19.84%	-4.34%	78.62%	-18.63%
EPS Growth	28.24%	17.43%	4.69%	8.21%	7.59%	0.64%	21.66%	-1.57%	81.38%	-16.42%
Operating Cash Flow Growth	20.45%	5.60%	3.85%	-5.45%	26.03%	36.56%	18.82%	-36.10%	10.63%	25.39%
Free Cash Flow Firm Growth	693.80%	-30.87%	-167.71%	165.08%	-97.95%	17,755.38%	85.90%	-10.62%	-21.91%	56.61%
Invested Capital Growth	2.07%	7.07%	21.48%	9.34%	13.95%	2.98%	-3.32%	-1.81%	12.51%	0.26%
Revenue Q/Q Growth	1.86%	1.39%	1.96%	3.48%	3.09%	0.27%	3.12%	0.70%	0.99%	2.20%
EBITDA Q/Q Growth	-1.43%	3.47%	-1.29%	5.61%	2.91%	-1.30%	0.95%	1.47%	4.09%	2.65%
EBIT Q/Q Growth	-1.57%	4.06%	-3.07%	7.22%	1.89%	-2.83%	1.09%	4.36%	5.31%	3.16%
NOPAT Q/Q Growth	3.73%	5.32%	-6.97%	9.39%	1.10%	-0.33%	-1.44%	3.84%	46.41%	-22.25%
Net Income Q/Q Growth	8.44%	4.55%	-3.67%	109.98%	-47.78%	-2.29%	-0.51%	4.94%	46.92%	-22.53%
EPS Q/Q Growth	9.00%	5.79%	-2.19%	5.07%	0.65%	-2.48%	0.00%	5.62%	46.98%	-21.27%
Operating Cash Flow Q/Q Growth	-5.53%	11.59%	-3.85%	13.86%	-10.49%	14.17%	14.46%	-3.73%	-7.14%	1.88%
Free Cash Flow Firm Q/Q Growth	-25.81%	21.95%	-93.99%	-35.59%	-99.18%	73.09%	78.96%	14.83%	-6.70%	12.73%
Invested Capital Q/Q Growth	1.79%	0.80%	2.22%	4.88%	12.07%	6.89%	-1.51%	-3.05%	5.46%	-2.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.31%	39.54%	38.56%	35.96%	34.82%	34.81%	35.60%	35.15%	35.08%	35.45%
EBITDA Margin	17.89%	16.99%	16.58%	16.89%	16.29%	16.49%	17.52%	14.85%	16.89%	17.26%
Operating Margin	13.58%	13.27%	12.10%	11.60%	12.20%	11.83%	12.65%	11.49%	14.09%	14.73%
EBIT Margin	13.97%	13.75%	13.04%	13.30%	12.58%	12.12%	13.29%	11.84%	14.52%	15.19%
Profit (Net Income) Margin	9.74%	10.41%	9.53%	18.77%	8.66%	8.31%	9.19%	8.08%	14.10%	10.78%
Tax Burden Percent	79.47%	81.16%	81.36%	155.59%	76.33%	76.98%	76.47%	75.96%	104.82%	75.89%
Interest Burden Percent	87.76%	93.24%	89.83%	90.70%	90.18%	89.11%	90.38%	89.91%	92.63%	93.48%
Effective Tax Rate	20.53%	18.84%	18.64%	22.31%	23.67%	23.02%	23.53%	24.04%	-4.82%	24.11%
Return on Invested Capital (ROIC)	16.31%	16.26%	13.82%	12.08%	13.10%	12.48%	14.42%	14.51%	23.88%	18.15%
ROIC Less NNEP Spread (ROIC-NNEP)	8.58%	13.95%	12.35%	47.67%	10.71%	9.36%	12.05%	10.85%	19.78%	15.04%
Return on Net Nonoperating Assets (RNNOA)	2.21%	4.35%	5.36%	27.69%	6.61%	5.01%	5.38%	4.48%	7.10%	4.00%
Return on Equity (ROE)	18.52%	20.62%	19.18%	39.77%	19.71%	17.50%	19.80%	18.98%	30.99%	22.15%
Cash Return on Invested Capital (CROIC)	14.27%	9.43%	-5.58%	3.16%	0.06%	9.55%	17.80%	16.33%	12.11%	17.89%
Operating Return on Assets (OROA)	12.42%	12.45%	11.27%	11.44%	11.10%	9.64%	10.86%	10.82%	13.84%	14.79%
Return on Assets (ROA)	8.66%	9.42%	8.23%	16.14%	7.64%	6.61%	7.50%	7.39%	13.44%	10.49%
Return on Common Equity (ROCE)	18.52%	20.58%	19.11%	39.70%	19.71%	17.50%	19.80%	18.98%	30.99%	22.15%
Return on Equity Simple (ROE_SIMPLE)	18.39%	20.79%	18.32%	40.11%	18.05%	16.81%	19.47%	19.35%	28.08%	21.50%
Net Operating Profit after Tax (NOPAT)	266	277	270	270	328	338	389	381	661	533
NOPAT Margin	10.79%	10.77%	9.85%	9.01%	9.31%	9.10%	9.68%	8.73%	14.77%	11.18%
Net Nonoperating Expense Percent (NNEP)	7.73%	2.32%	1.47%	-35.59%	2.39%	3.12%	2.37%	3.65%	4.10%	3.11%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	11.73%	18.81%	14.76%
Cost of Revenue to Revenue	60.69%	60.46%	61.44%	64.04%	65.18%	65.19%	64.40%	64.85%	64.92%	64.55%
SG&A Expenses to Revenue	24.71%	25.40%	25.19%	23.12%	22.58%	21.29%	21.52%	21.47%	20.40%	20.29%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.73%	26.27%	26.46%	24.36%	22.62%	22.98%	22.95%	23.66%	20.99%	20.73%
Earnings before Interest and Taxes (EBIT)	344	354	357	399	443	449	535	517	650	724
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	440	437	454	507	573	612	705	649	756	823
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.75	3.50	4.00	3.43	4.49	4.09	5.08	4.51	2.76	3.17
Price to Tangible Book Value (P/TBV)	29.25	32.57	0.00	0.00	0.00	0.00	0.00	157.57	12.11	10.93
Price to Revenue (P/Rev)	1.99	1.75	2.08	1.61	2.16	2.02	2.40	1.88	1.38	1.59
Price to Earnings (P/E)	20.42	16.70	21.65	8.54	24.90	24.31	26.10	23.29	9.81	14.75
Dividend Yield	0.00%	0.00%	0.81%	1.18%	0.85%	0.99%	0.84%	1.11%	1.61%	1.42%
Earnings Yield	4.90%	5.99%	4.62%	11.71%	4.02%	4.11%	3.83%	4.29%	10.19%	6.78%
Enterprise Value to Invested Capital (EV/IC)	3.18	2.83	3.00	2.46	3.21	3.06	3.92	3.46	2.35	2.76
Enterprise Value to Revenue (EV/Rev)	2.13	1.94	2.34	1.92	2.43	2.27	2.59	2.06	1.54	1.70
Enterprise Value to EBITDA (EV/EBITDA)	11.90	11.40	14.13	11.35	14.94	13.75	14.75	13.88	9.10	9.88
Enterprise Value to EBIT (EV/EBIT)	15.23	14.08	17.97	14.41	19.34	18.70	19.45	17.42	10.58	11.22
Enterprise Value to NOPAT (EV/NOPAT)	19.72	17.98	23.79	21.27	26.14	24.89	26.71	23.63	10.40	15.25
Enterprise Value to Operating Cash Flow (EV/OCF)	15.99	14.40	17.86	16.94	20.02	14.39	14.98	20.31	14.01	13.20
Enterprise Value to Free Cash Flow (EV/FCFF)	22.54	31.00	0.00	81.30	5,919.40	32.53	21.65	20.99	20.52	15.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.61	0.70	0.85	0.93	0.85	0.87	0.87	0.78	0.56	0.51
Long-Term Debt to Equity	0.57	0.54	0.70	0.69	0.79	0.71	0.67	0.68	0.37	0.50
Financial Leverage	0.26	0.31	0.43	0.58	0.62	0.54	0.45	0.41	0.36	0.27
Leverage Ratio	2.14	2.19	2.33	2.46	2.58	2.65	2.64	2.57	2.31	2.11
Compound Leverage Factor	1.88	2.04	2.09	2.23	2.33	2.36	2.39	2.31	2.14	1.97
Debt to Total Capital	37.96%	41.00%	45.98%	48.15%	46.08%	46.45%	46.61%	43.85%	36.04%	33.83%
Short-Term Debt to Total Capital	2.88%	9.10%	7.91%	12.13%	3.30%	8.28%	10.79%	5.45%	12.58%	0.72%
Long-Term Debt to Total Capital	35.07%	31.90%	38.06%	36.02%	42.77%	38.17%	35.81%	38.41%	23.46%	33.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.21%	0.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.04%	58.79%	53.85%	51.85%	53.92%	53.55%	53.39%	56.15%	63.96%	66.17%
Debt to EBITDA	1.81	2.05	2.68	2.57	2.52	2.60	2.35	2.20	1.68	1.48
Net Debt to EBITDA	0.77	1.08	1.57	1.84	1.70	1.49	1.07	1.20	0.90	0.67
Long-Term Debt to EBITDA	1.68	1.60	2.22	1.92	2.34	2.14	1.81	1.92	1.09	1.45
Debt to NOPAT	3.00	3.24	4.51	4.82	4.40	4.71	4.25	3.74	1.92	2.29
Net Debt to NOPAT	1.28	1.70	2.64	3.46	2.98	2.70	1.94	2.04	1.03	1.03
Long-Term Debt to NOPAT	2.78	2.52	3.73	3.61	4.09	3.87	3.27	3.27	1.25	2.24
Altman Z-Score	3.72	3.37	3.18	2.89	3.14	2.89	3.40	3.53	3.29	3.80
Noncontrolling Interest Sharing Ratio	0.00%	0.17%	0.34%	0.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.01	1.68	1.71	1.39	1.70	1.45	1.47	1.61	1.44	2.16
Quick Ratio	1.75	1.42	1.43	1.17	1.52	1.30	1.37	1.49	1.29	1.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	232	161	-109	71	1.45	258	480	429	335	525
Operating Cash Flow to CapEx	539.56%	424.89%	647.07%	402.69%	584.73%	839.97%	1,478.55%	877.62%	886.01%	768.02%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.89	0.91	0.86	0.86	0.88	0.80	0.82	0.91	0.95	0.97
Accounts Receivable Turnover	4.41	4.27	4.18	4.09	4.17	4.13	4.55	4.64	4.24	4.12
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	14.01	13.95	13.68	14.30	15.09	15.29	18.03	22.09	24.16	23.97
Accounts Payable Turnover	116.55	156.58	135.50	66.69	71.08	134.75	133.20	93.26	91.47	95.85
Days Sales Outstanding (DSO)	82.75	85.57	87.24	89.24	87.53	88.33	80.25	78.60	86.06	88.62
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3.13	2.33	2.69	5.47	5.14	2.71	2.74	3.91	3.99	3.81
Cash Conversion Cycle (CCC)	79.62	83.24	84.55	83.76	82.39	85.62	77.51	74.68	82.07	84.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,645	1,761	2,139	2,339	2,665	2,745	2,654	2,606	2,932	2,939
Invested Capital Turnover	1.51	1.51	1.40	1.34	1.41	1.37	1.49	1.66	1.62	1.62
Increase / (Decrease) in Invested Capital	33	116	378	200	326	79	-91	-48	326	7.76
Enterprise Value (EV)	5,237	4,978	6,412	5,752	8,566	8,406	10,398	9,012	6,878	8,125
Market Capitalization	4,897	4,504	5,697	4,817	7,590	7,495	9,642	8,232	6,195	7,575
Book Value per Share	$6.13	$6.41	$7.38	$7.39	$8.89	$9.69	$10.09	$9.96	$12.39	$13.55
Tangible Book Value per Share	$0.79	$0.69	($0.23)	($0.88)	($0.61)	($0.52)	($0.02)	$0.29	$2.82	$3.93
Total Capital	2,102	2,189	2,645	2,708	3,132	3,425	3,553	3,252	3,515	3,611
Total Debt	798	897	1,216	1,304	1,443	1,591	1,656	1,426	1,267	1,221
Total Long-Term Debt	737	698	1,007	976	1,340	1,307	1,272	1,249	825	1,195
Net Debt	340	470	711	935	976	910	756	780	683	550
Capital Expenditures (CapEx)	61	81	55	84	73	70	47	51	55	80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	210	272	300	339	278	149	97	207	432	471
Debt-free Net Working Capital (DFNWC)	661	695	804	707	745	830	996	853	1,016	1,143
Net Working Capital (NWC)	601	496	595	379	641	546	613	676	574	1,116
Net Nonoperating Expense (NNE)	26	9.38	8.70	-293	23	29	20	28	30	19
Net Nonoperating Obligations (NNO)	340	470	711	935	976	910	756	780	683	550
Total Depreciation and Amortization (D&A)	96	83	97	108	130	162	170	132	106	99
Debt-free, Cash-free Net Working Capital to Revenue	8.55%	10.59%	10.96%	11.29%	7.89%	4.03%	2.41%	4.73%	9.65%	9.88%
Debt-free Net Working Capital to Revenue	26.87%	27.03%	29.39%	23.57%	21.16%	22.37%	24.77%	19.52%	22.69%	23.97%
Net Working Capital to Revenue	24.40%	19.28%	21.74%	12.62%	18.22%	14.73%	15.24%	15.47%	12.81%	23.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.11	$1.30	$1.36	$1.48	$1.60	$1.62	$1.97	$1.92	$3.46	$2.88
Adjusted Weighted Average Basic Shares Outstanding	216.61M	206.86M	193.86M	190.67M	190.07M	190.40M	187.80M	184.18M	182.35M	178.39M
Adjusted Diluted Earnings per Share	$1.09	$1.28	$1.34	$1.45	$1.56	$1.57	$1.91	$1.88	$3.41	$2.85
Adjusted Weighted Average Diluted Shares Outstanding	219.15M	210.13M	197.05M	193.98M	195.16M	195.78M	192.96M	188.09M	185.14M	180.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	210.55M	198.97M	193.48M	189.46M	190.40M	188.14M	185.17M	183.98M	180.73M	175.67M
Normalized Net Operating Profit after Tax (NOPAT)	266	277	270	270	328	338	389	381	442	533
Normalized NOPAT Margin	10.79%	10.77%	9.85%	9.01%	9.31%	9.10%	9.68%	8.73%	9.86%	11.18%
Pre Tax Income Margin	12.26%	12.82%	11.71%	12.06%	11.35%	10.80%	12.01%	10.64%	13.45%	14.20%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	17.90%	10.14%	21.21%	24.07%	21.78%	25.99%	15.84%	21.12%
Augmented Payout Ratio	94.70%	129.13%	102.16%	37.51%	31.06%	68.55%	102.50%	86.56%	51.57%	70.31%

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.38%	2.82%	1.95%	1.50%	2.23%	3.96%	3.85%	6.39%	6.62%	8.94%
EBITDA Growth	-6.58%	5.95%	0.57%	34.24%	16.74%	17.73%	8.94%	5.80%	9.63%	10.76%
EBIT Growth	-1.49%	18.49%	7.50%	52.49%	25.05%	23.63%	12.50%	8.27%	11.72%	12.96%
NOPAT Growth	-5.38%	18.08%	8.53%	47.55%	21.44%	221.35%	7.61%	5.14%	9.30%	-50.58%
Net Income Growth	-6.39%	22.75%	10.32%	62.20%	22.69%	224.72%	10.22%	4.94%	12.95%	-51.28%
EPS Growth	-3.77%	26.32%	11.76%	65.79%	25.49%	227.08%	12.28%	6.35%	15.63%	-49.04%
Operating Cash Flow Growth	7.76%	-6.96%	70.19%	67.54%	-28.53%	-16.43%	24.96%	22.06%	41.44%	5.91%
Free Cash Flow Firm Growth	746.94%	-17.04%	3,943.10%	108.88%	-69.61%	-119.06%	-199.80%	-216.35%	-345.14%	621.41%
Invested Capital Growth	-0.24%	-1.81%	-2.13%	0.60%	3.43%	12.51%	10.35%	8.90%	7.90%	0.26%
Revenue Q/Q Growth	2.01%	-0.76%	-1.20%	1.49%	2.74%	0.92%	-1.31%	3.98%	2.95%	3.12%
EBITDA Q/Q Growth	17.65%	1.07%	4.70%	7.83%	2.31%	1.93%	-3.12%	4.71%	6.01%	2.98%
EBIT Q/Q Growth	26.19%	3.09%	6.83%	9.73%	3.48%	1.92%	-2.79%	5.61%	6.77%	3.05%
NOPAT Q/Q Growth	25.65%	-10.12%	19.44%	9.39%	3.42%	137.82%	-60.00%	6.87%	7.51%	7.54%
Net Income Q/Q Growth	33.73%	-6.40%	18.27%	9.57%	1.15%	147.73%	-59.85%	4.31%	8.88%	6.85%
EPS Q/Q Growth	34.21%	-5.88%	18.75%	10.53%	1.59%	145.31%	-59.24%	4.69%	10.45%	8.11%
Operating Cash Flow Q/Q Growth	120.84%	1.61%	-114.83%	603.31%	-5.79%	18.81%	-113.32%	918.72%	9.17%	-11.04%
Free Cash Flow Firm Q/Q Growth	119.63%	28.01%	22.46%	-39.33%	-68.05%	-180.27%	-541.39%	29.27%	32.68%	270.73%
Invested Capital Q/Q Growth	-3.68%	-3.05%	8.31%	-0.52%	-0.97%	5.46%	6.22%	-1.83%	-1.88%	-2.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.45%	34.94%	33.99%	35.28%	35.47%	35.56%	35.05%	35.40%	35.63%	35.70%
EBITDA Margin	14.94%	15.21%	16.12%	17.13%	17.06%	17.23%	16.91%	17.03%	17.54%	17.51%
Operating Margin	11.78%	11.59%	13.32%	14.23%	14.59%	14.20%	14.14%	14.47%	15.00%	15.23%
EBIT Margin	12.10%	12.57%	13.60%	14.70%	14.81%	14.95%	14.73%	14.96%	15.51%	15.50%
Profit (Net Income) Margin	8.63%	8.14%	9.74%	10.52%	10.35%	25.41%	10.34%	10.37%	10.97%	11.36%
Tax Burden Percent	79.16%	72.87%	76.62%	77.31%	75.91%	183.82%	74.79%	75.11%	75.69%	77.74%
Interest Burden Percent	90.04%	88.81%	93.50%	92.53%	92.12%	92.46%	93.85%	92.31%	93.41%	94.29%
Effective Tax Rate	20.84%	27.13%	23.38%	22.69%	24.09%	-83.82%	25.21%	24.89%	24.31%	22.26%
Return on Invested Capital (ROIC)	15.04%	14.03%	15.71%	17.33%	17.96%	42.20%	16.10%	17.02%	18.33%	19.23%
ROIC Less NNEP Spread (ROIC-NNEP)	14.13%	13.60%	15.19%	16.77%	17.01%	41.13%	15.79%	16.28%	17.65%	18.26%
Return on Net Nonoperating Assets (RNNOA)	6.51%	5.61%	7.78%	8.72%	7.85%	14.77%	6.40%	6.08%	5.51%	4.86%
Return on Equity (ROE)	21.55%	19.64%	23.50%	26.04%	25.81%	56.96%	22.50%	23.09%	23.84%	24.08%
Cash Return on Invested Capital (CROIC)	13.89%	16.33%	15.83%	14.74%	13.14%	12.11%	12.69%	14.50%	16.12%	17.89%
Operating Return on Assets (OROA)	10.96%	11.49%	12.60%	14.36%	14.37%	14.25%	14.40%	14.21%	14.58%	15.09%
Return on Assets (ROA)	7.81%	7.44%	9.03%	10.28%	10.05%	24.22%	10.10%	9.85%	10.31%	11.06%
Return on Common Equity (ROCE)	21.55%	19.64%	23.50%	26.04%	25.81%	56.96%	22.50%	23.09%	23.84%	24.08%
Return on Equity Simple (ROE_SIMPLE)	19.45%	0.00%	18.87%	21.10%	21.38%	0.00%	27.94%	27.71%	27.69%	0.00%
Net Operating Profit after Tax (NOPAT)	104	93	111	122	126	299	120	128	137	148
NOPAT Margin	9.32%	8.44%	10.21%	11.00%	11.07%	26.10%	10.58%	10.87%	11.35%	11.84%
Net Nonoperating Expense Percent (NNEP)	0.91%	0.44%	0.53%	0.56%	0.95%	1.07%	0.32%	0.74%	0.68%	0.96%
Return On Investment Capital (ROIC_SIMPLE)	-	2.86%	-	-	-	8.51%	-	-	-	4.09%
Cost of Revenue to Revenue	64.55%	65.06%	66.01%	64.72%	64.53%	64.44%	64.95%	64.60%	64.37%	64.30%
SG&A Expenses to Revenue	20.83%	21.46%	19.87%	20.75%	20.23%	20.71%	20.78%	20.37%	20.09%	19.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.67%	23.35%	20.67%	21.05%	20.88%	21.36%	20.91%	20.93%	20.63%	20.47%
Earnings before Interest and Taxes (EBIT)	134	139	148	163	168	171	167	176	188	194
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	166	168	176	189	194	197	191	200	212	219
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.52	4.51	4.33	3.52	3.21	2.76	2.58	2.48	2.92	3.17
Price to Tangible Book Value (P/TBV)	0.00	157.57	52.80	38.44	23.92	12.11	10.36	9.34	10.30	10.93
Price to Revenue (P/Rev)	1.80	1.88	1.90	1.54	1.46	1.38	1.31	1.26	1.50	1.59
Price to Earnings (P/E)	23.23	23.29	22.93	16.68	15.02	9.81	9.23	8.94	10.54	14.75
Dividend Yield	1.13%	1.11%	1.13%	1.42%	1.51%	1.61%	1.72%	1.80%	1.52%	1.42%
Earnings Yield	4.30%	4.29%	4.36%	6.00%	6.66%	10.19%	10.83%	11.18%	9.49%	6.78%
Enterprise Value to Invested Capital (EV/IC)	3.27	3.46	3.27	2.74	2.60	2.35	2.17	2.13	2.53	2.76
Enterprise Value to Revenue (EV/Rev)	2.02	2.06	2.10	1.74	1.63	1.54	1.49	1.42	1.63	1.70
Enterprise Value to EBITDA (EV/EBITDA)	13.73	13.88	14.19	10.99	9.95	9.10	8.74	8.32	9.47	9.88
Enterprise Value to EBIT (EV/EBIT)	17.72	17.42	17.49	13.15	11.70	10.58	10.09	9.55	10.82	11.22
Enterprise Value to NOPAT (EV/NOPAT)	23.92	23.63	23.65	17.88	15.99	10.40	10.09	9.65	11.08	15.25
Enterprise Value to Operating Cash Flow (EV/OCF)	19.07	20.31	17.62	12.95	13.67	14.01	13.51	12.13	12.57	13.20
Enterprise Value to Free Cash Flow (EV/FCFF)	23.50	20.99	20.43	18.62	20.10	20.52	17.90	15.32	16.30	15.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.86	0.78	0.75	0.71	0.65	0.56	0.56	0.70	0.68	0.51
Long-Term Debt to Equity	0.43	0.68	0.65	0.64	0.61	0.37	0.36	0.52	0.50	0.50
Financial Leverage	0.46	0.41	0.51	0.52	0.46	0.36	0.41	0.37	0.31	0.27
Leverage Ratio	2.60	2.57	2.51	2.45	2.44	2.31	2.19	2.26	2.25	2.11
Compound Leverage Factor	2.34	2.28	2.35	2.27	2.25	2.13	2.05	2.09	2.10	1.99
Debt to Total Capital	46.11%	43.85%	42.94%	41.40%	39.49%	36.04%	36.02%	41.13%	40.46%	33.83%
Short-Term Debt to Total Capital	22.88%	5.45%	6.11%	3.92%	2.44%	12.58%	13.24%	10.72%	10.59%	0.72%
Long-Term Debt to Total Capital	23.23%	38.41%	36.83%	37.49%	37.05%	23.46%	22.78%	30.41%	29.87%	33.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.89%	56.15%	57.06%	58.60%	60.51%	63.96%	63.98%	58.87%	59.54%	66.17%
Debt to EBITDA	2.32	2.20	2.23	1.96	1.81	1.68	1.68	2.09	2.03	1.48
Net Debt to EBITDA	1.51	1.20	1.38	1.25	1.06	0.90	1.06	0.92	0.75	0.67
Long-Term Debt to EBITDA	1.17	1.92	1.91	1.77	1.69	1.09	1.06	1.54	1.50	1.45
Debt to NOPAT	4.03	3.74	3.71	3.18	2.90	1.92	1.94	2.42	2.37	2.29
Net Debt to NOPAT	2.62	2.04	2.30	2.04	1.71	1.03	1.22	1.07	0.88	1.03
Long-Term Debt to NOPAT	2.03	3.27	3.19	2.88	2.72	1.25	1.22	1.79	1.75	2.24
Altman Z-Score	2.99	3.26	3.49	3.17	3.08	2.96	3.03	2.79	2.99	3.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.08	1.61	1.84	1.88	1.91	1.44	1.54	1.89	1.85	2.16
Quick Ratio	0.93	1.49	1.65	1.61	1.63	1.29	1.37	1.73	1.73	1.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	110	141	173	105	33	-27	-172	-122	-82	140
Operating Cash Flow to CapEx	2,705.17%	1,500.84%	-271.02%	1,497.74%	1,215.11%	1,061.02%	-106.48%	1,092.53%	1,156.14%	1,180.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.91	0.91	0.93	0.98	0.97	0.95	0.98	0.95	0.94	0.97
Accounts Receivable Turnover	4.46	4.64	4.44	4.36	4.33	4.24	4.20	4.23	4.11	4.12
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	22.36	22.09	23.00	23.90	24.62	24.16	24.23	24.20	24.09	23.97
Accounts Payable Turnover	106.90	93.26	130.92	83.26	105.70	91.47	115.16	84.29	133.39	95.85
Days Sales Outstanding (DSO)	81.79	78.60	82.14	83.71	84.34	86.06	86.94	86.19	88.76	88.62
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3.41	3.91	2.79	4.38	3.45	3.99	3.17	4.33	2.74	3.81
Cash Conversion Cycle (CCC)	78.38	74.68	79.35	79.32	80.89	82.07	83.77	81.86	86.02	84.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,688	2,606	2,822	2,807	2,780	2,932	3,114	3,057	3,000	2,939
Invested Capital Turnover	1.61	1.66	1.54	1.58	1.62	1.62	1.52	1.57	1.61	1.62
Increase / (Decrease) in Invested Capital	-6.57	-48	-61	17	92	326	292	250	220	7.76
Enterprise Value (EV)	8,787	9,012	9,229	7,678	7,224	6,878	6,744	6,513	7,591	8,125
Market Capitalization	7,824	8,232	8,332	6,804	6,453	6,195	5,928	5,794	6,986	7,575
Book Value per Share	$9.44	$9.96	$10.46	$10.50	$11.08	$12.39	$12.72	$12.99	$13.44	$13.55
Tangible Book Value per Share	($0.27)	$0.29	$0.86	$0.96	$1.49	$2.82	$3.17	$3.45	$3.81	$3.93
Total Capital	3,214	3,252	3,374	3,299	3,321	3,515	3,592	3,971	4,022	3,611
Total Debt	1,482	1,426	1,449	1,366	1,312	1,267	1,294	1,634	1,628	1,221
Total Long-Term Debt	747	1,249	1,243	1,237	1,230	825	818	1,208	1,201	1,195
Net Debt	963	780	897	875	771	683	816	719	605	550
Capital Expenditures (CapEx)	8.35	15	13	11	13	18	24	19	20	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	342	207	443	455	431	432	642	580	510	471
Debt-free Net Working Capital (DFNWC)	860	853	995	946	972	1,016	1,121	1,494	1,532	1,143
Net Working Capital (NWC)	125	676	789	817	891	574	645	1,068	1,106	1,116
Net Nonoperating Expense (NNE)	7.73	3.38	5.09	5.37	8.19	7.83	2.71	5.88	4.66	5.93
Net Nonoperating Obligations (NNO)	956	780	897	875	771	683	816	719	605	550
Total Depreciation and Amortization (D&A)	31	29	27	27	26	26	25	24	24	25
Debt-free, Cash-free Net Working Capital to Revenue	7.87%	4.73%	10.08%	10.31%	9.72%	9.65%	14.22%	12.64%	10.92%	9.88%
Debt-free Net Working Capital to Revenue	19.82%	19.52%	22.66%	21.45%	21.92%	22.69%	24.80%	32.56%	32.85%	23.97%
Net Working Capital to Revenue	2.89%	15.47%	17.97%	18.53%	20.09%	12.81%	14.27%	23.28%	23.71%	23.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.52	$0.49	$0.58	$0.63	$0.65	$1.60	$0.65	$0.68	$0.75	$0.80
Adjusted Weighted Average Basic Shares Outstanding	183.31M	184.18M	183.80M	183.23M	181.40M	182.35M	180.42M	179.65M	177.60M	178.39M
Adjusted Diluted Earnings per Share	$0.51	$0.48	$0.57	$0.63	$0.64	$1.57	$0.64	$0.67	$0.74	$0.80
Adjusted Weighted Average Diluted Shares Outstanding	187.40M	188.09M	187.59M	185.83M	183.80M	185.14M	181.94M	180.91M	179.71M	180.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	183.26M	183.98M	184.15M	181.32M	181.41M	180.73M	179.98M	178.18M	176.36M	175.67M
Normalized Net Operating Profit after Tax (NOPAT)	104	93	111	122	126	114	120	128	137	148
Normalized NOPAT Margin	9.32%	8.44%	10.21%	11.00%	11.07%	9.94%	10.58%	10.87%	11.35%	11.84%
Pre Tax Income Margin	10.90%	11.17%	12.71%	13.60%	13.64%	13.83%	13.82%	13.81%	14.49%	14.62%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	26.42%	25.99%	25.86%	23.55%	22.84%	15.84%	15.92%	16.14%	16.07%	21.12%
Augmented Payout Ratio	26.42%	86.56%	25.86%	23.55%	22.84%	51.57%	15.92%	16.14%	16.07%	70.31%

Frequently Asked Questions About Genpact's Financials

When does Genpact's fiscal year end?

According to the most recent income statement we have on file, Genpact's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Genpact's net income changed over the last 9 years?

Genpact's net income appears to be on an upward trend, with a most recent value of $513.67 million in 2024, rising from $239.82 million in 2015. The previous period was $631.26 million in 2023. Find out what analysts predict for Genpact in the coming months.

What is Genpact's operating income?

Genpact's total operating income in 2024 was $702.06 million, based on the following breakdown:

Total Gross Profit: $1.69 billion
Total Operating Expenses: $988.01 million

How has Genpact revenue changed over the last 9 years?

Over the last 9 years, Genpact's total revenue changed from $2.46 billion in 2015 to $4.77 billion in 2024, a change of 93.7%.

How much debt does Genpact have?

Genpact's total liabilities were at $2.60 billion at the end of 2024, a 1.6% increase from 2023, and a 74.4% increase since 2015.

How much cash does Genpact have?

In the past 9 years, Genpact's cash and equivalents has ranged from $368.40 million in 2018 to $899.46 million in 2021, and is currently $648.25 million as of their latest financial filing in 2024.

How has Genpact's book value per share changed over the last 9 years?

Over the last 9 years, Genpact's book value per share changed from 6.13 in 2015 to 13.55 in 2024, a change of 120.9%.

Related Companies

This page (NYSE:G) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genpact (G) Financials

Frequently Asked Questions About Genpact's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Genpact (G) Financials

Annual Income Statements for Genpact

Quarterly Income Statements for Genpact

Annual Cash Flow Statements for Genpact

Quarterly Cash Flow Statements for Genpact

Annual Balance Sheets for Genpact

Quarterly Balance Sheets for Genpact

Annual Metrics and Ratios for Genpact

Quarterly Metrics and Ratios for Genpact

Frequently Asked Questions About Genpact's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools